• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Amgen

Amgen

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Amgen is the latest to raise drug prices despite public outcry

    Amgen is the latest to raise drug prices despite public outcry

  2. Amgen Profit Rises 13%, 2016 Outlook Raised -- Update

    Amgen Profit Rises 13%, 2016 Outlook Raised -- Update

  3. UPDATE: Bull trend intact, S&P 500 stages garden-variety pullback

    UPDATE: Bull trend intact, S&P 500 stages garden-variety pullback

  4. Amgen Biosimilar Gets Thumbs-Up From FDA Panel

    Amgen Biosimilar Gets Thumbs-Up From FDA Panel

  5. UPDATE: These drugs could cut American health costs by $250 billion (if only we could take them)

    UPDATE: These drugs could cut American health costs by $250 billion (if only we could take them)

  6. UPDATE: These drugs could cut American health -2-

    UPDATE: These drugs could cut American health -2-

  7. UPDATE: These drugs could cut American health -2-

    UPDATE: These drugs could cut American health -2-

  8. UPDATE: These drugs could cut American health -2-

    UPDATE: These drugs could cut American health -2-

  9. UPDATE: These drugs could cut American health costs by $250 billion (if only we could take them)

    UPDATE: These drugs could cut American health costs by $250 billion (if only we could take them)

  10. UPDATE: These drugs could cut American health costs by $250 billion (if only we could take them)

    UPDATE: These drugs could cut American health costs by $250 billion (if only we could take them)

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.